Analysts are on the Bearish side about Thermo Fisher Scientific Inc. (NYSE:TMO) this week.

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo
Investors sentiment increased to 1.06 in Q2 2019. Its up 0.10, from 0.96 in 2019Q1. It improved, as 35 investors sold Thermo Fisher Scientific Inc. shares while 429 reduced holdings. 121 funds opened positions while 373 raised stakes. 338.08 million shares or 0.28% more from 337.12 million shares in 2019Q1 were reported.
Amundi Pioneer Asset holds 0.43% or 1.79M shares in its portfolio. Franklin Street Advsr Nc accumulated 23,549 shares or 0.89% of the stock. Cohen Capital Mgmt Inc invested in 5.32% or 77,685 shares. 24,324 are owned by Perella Weinberg Partners Cap L P. Baldwin Investment Limited Liability Company accumulated 0.62% or 7,280 shares. Capital Mngmt Associate New York, a New York-based fund reported 3,000 shares. Davenport Co Limited Liability Co has 0.01% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 2,538 shares. Adage Capital Prtnrs Gru Inc Limited owns 0.36% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 490,995 shares. Moreover, Partner Fund Mgmt Lp has 0.9% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Waratah Cap Advsrs holds 4.01% or 122,725 shares. Profund Advisors Llc holds 11,808 shares. Price T Rowe Associates Md invested in 0.71% or 17.14M shares. Fifth Third Bancshares has invested 0.48% in Thermo Fisher Scientific Inc. (NYSE:TMO). Neville Rodie & Shaw Inc holds 110,113 shares or 3.42% of its portfolio. California-based Mirador Cap Prtn L P has invested 1.33% in Thermo Fisher Scientific Inc. (NYSE:TMO).

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 7 analysts covering Thermo Fisher (NYSE:TMO), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Thermo Fisher has $32100 highest and $288 lowest target. $307’s average target is 3.08% above currents $297.83 stock price. Thermo Fisher had 13 analyst reports since March 18, 2019 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, March 26 by BTIG Research. The rating was maintained by Deutsche Bank with “Buy” on Friday, March 22. On Tuesday, July 16 the stock rating was downgraded by Needham to “Buy”. The firm earned “Buy” rating on Thursday, May 23 by UBS. UBS maintained Thermo Fisher Scientific Inc. (NYSE:TMO) on Monday, March 25 with “Buy” rating. Argus Research maintained the shares of TMO in report on Wednesday, May 1 with “Buy” rating. The rating was maintained by Robert W. Baird on Tuesday, March 26 with “Outperform”. Needham maintained the stock with “Buy” rating in Thursday, July 25 report. The rating was maintained by Barclays Capital on Monday, March 18 with “Buy”. Below is a list of Thermo Fisher Scientific Inc. (NYSE:TMO) latest ratings and price target changes.

25/07/2019 Broker: Needham Rating: Buy Old Target: $315.0000 New Target: $321.0000 Maintain
16/07/2019 Broker: Needham Old Rating: Strong Buy New Rating: Buy New Target: $315.0000 Downgrade
29/05/2019 Broker: BidaskScore Rating: Buy Upgrade
23/05/2019 Broker: UBS Rating: Buy Old Target: $305.0000 New Target: $320.0000 Maintain
10/05/2019 Broker: BidaskScore Rating: Buy Downgrade
04/05/2019 Broker: BidaskScore Rating: Buy Upgrade
01/05/2019 Broker: Argus Research Old Rating: Buy New Rating: Buy Old Target: $285.0000 New Target: $310.0000 Maintain
26/03/2019 Broker: BTIG Research Rating: Buy New Target: $310 Maintain
25/03/2019 Broker: UBS Rating: Buy New Target: $305 Maintain
26/03/2019 Broker: Robert W. Baird Old Rating: Outperform New Rating: Outperform Old Target: $270 New Target: $288 Maintain

The stock increased 0.97% or $2.86 during the last trading session, reaching $297.83. About 781,292 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 20.35% since September 13, 2018 and is uptrending. It has outperformed by 20.35% the S&P500.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. The company has market cap of $119.27 billion. The Company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. It has a 34.01 P/E ratio. The Company’s Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Finance.Yahoo.com which released: “At US$292, Is Thermo Fisher Scientific Inc. (NYSE:TMO) Worth Looking At Closely? – Yahoo Finance” on June 27, 2019, also Streetinsider.com with their article: “Thermo Fisher Scientific (TMO) Reports Election of Debora Spar to Board – StreetInsider.com” published on September 05, 2019, Finance.Yahoo.com published: “Do Thermo Fisher Scientific’s (NYSE:TMO) Earnings Warrant Your Attention? – Yahoo Finance” on June 17, 2019. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: Seekingalpha.com and their article: “Thermo Fisher to develop companion diagnostic for Lilly’s selpercatinib – Seeking Alpha” published on September 09, 2019 as well as Streetinsider.com‘s news article titled: “Thermo Fisher Scientific (TMO), Danaher (DHR) Said Among Firms Eyeing KKR’s (KKR) LGC – Bloomberg (Earlier) – StreetInsider.com” with publication date: September 06, 2019.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.